Search results for "choline"

showing 10 items of 1138 documents

Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic system.

2015

This special issue of International Immunopharmacology is the proceedings of the Fourth International Symposium on Non-neuronal Acetylcholine that was held on August 28-30, 2014 at the Justus Liebig University of Giessen in Germany. It contains original contributions of meeting participants covering the significant progress in understanding of the biological and medical significance of the non-neuronal cholinergic system extending from exciting insights into molecular mechanisms regulating this system via miRNAs over the discovery of novel cholinergic cellular signaling circuitries to clinical implications in cancer, wound healing, immunity and inflammation, cardiovascular, respiratory and …

PharmacologyInflammationWound HealingStem CellseducationImmunologyRespiratory Tract DiseasesBiologyImmunopharmacologyAcetylcholineMicroRNAsGene Expression RegulationCardiovascular DiseasesNeoplasmsImmunologyCholinergic systemImmunology and AllergyCholinergicAnimalsNeuroscienceSignal TransductionInternational immunopharmacology
researchProduct

Über die Abhängigkeit der Acetylcholinwirkung von der äusseren Ca-Konzentration bei isolierten Meerschweinchenvorhöfen

1966

In the left auricles of guinea-pigs, Ca-ions have an antagonistic effect on the negative inotropic action of ACh. This effect is independent of the degree of shortening of the action potential by ACh.

PharmacologyInotropemedicine.medical_specialtyChemistryCell BiologyGuinea pig atriaCellular and Molecular NeuroscienceEndocrinologyInternal medicinemedicineMolecular MedicineMolecular BiologyAcetylcholinemedicine.drugExperientia
researchProduct

Pharmacological evaluation of the dichloromethanol extract fromInula crithmoides L.

1995

The pharmacological effect of the dichloromethanol extract of Inula crithmoides L. was analysed in in vitro and in vivo models. The extract dose-dependently decreased arterial blood pressure and furthermore it showed low acute toxicity, CNS depressor activity and analgesic and antiinflammatory effects. Preincubation of the guinea-pig ileum and rat duodenum (100 μg/mL) produced a significant reduction in the contractile effects of histamine and acetylcholine and a concentration-related inhibition of the effects of serotonin. Following further fractionation the methylene chloride/acetone (50/50) fraction caused a significant decrease in motor activity and significantly reduced the threshold o…

PharmacologyInulabiologyAnalgesicBiological activityPharmacologybiology.organism_classificationAcute toxicitychemistry.chemical_compoundchemistryIn vivoAnesthesiaToxicitymedicineHistamineAcetylcholinemedicine.drugPhytotherapy Research
researchProduct

The variation of acetylcholine release from myenteric neurones with stimulation frequency and train length. Role of presynaptic muscarine receptors.

1983

1. The effects of scopolamine on the release of 3H-acetylcholine (ACh) from the guinea-pig myenteric plexus were studied at different stimulation frequencies (0.03–10 Hz) and train lengths (1–180 pulses). Release of 3H-ACh was measured in the absence of cholinesterase inhibitors as the outflow of tritium from myenteric plexus-longitudinal muscle preparations preloaded with 3H-choline. 2. In control experiments the volley output of 3H-ACh declined with increasing train length and increasing stimulation frequency. Stimulation by one pulse produced the highest volley output. 3. Scopolamine facilitated the evoked output of 3H-ACh via blockade of presynaptic muscarine receptors. A significant in…

PharmacologyMuscarinePulse (signal processing)Guinea PigsScopolamineMyenteric PlexusStimulationGeneral MedicineInhibitory postsynaptic potentialReceptors MuscarinicAcetylcholineElectric StimulationFeedbackchemistry.chemical_compoundchemistryNegative feedbackMuscarinic acetylcholine receptormedicineAnimalsNeuroscienceAcetylcholineMyenteric plexusmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Acetylcholine release at motor endplates and autonomic neuroeffector junctions: a comparison.

1996

Acetylcholine released at motor endplates and at autonomic neuroeffector junctions binds to nicotinic and muscarinic receptors to affect the activity of the corresponding target cells. Additionally, nicotonic and muscarinic receptors modulate various intracellular regulatory pathways (second messengers, gene expression) and mediate trophic effects. To maintain homeostasis of the individual cell and of the whole organism the release of acetylcholine has to be strictly controlled within both nervous systems. The basic events of synthesis, storage, and release are comparable at motoneurones and autonomic neurones, but mechanisms regulating transmitter release appear to differ. The motor endpla…

PharmacologyMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2BiologyMotor EndplateReceptors MuscarinicAcetylcholineNeuroeffector junctionNicotinic agonistMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptorMuscarinic acetylcholine receptor M4medicineNeuroeffector JunctionAnimalsNeuroscienceAcetylcholinemedicine.drugPharmacological research
researchProduct

The Non-neuronal Cholinergic System

2001

An increasing body of knowledge indicates that the cholinergic system is not confined to the nervous system, but is practically ubiquitous. The present paper will address the question of the non-neuronal cholinergic system in vascular endothelial cells (EC). In tissue sections of human skin, immunohistochemical studies using confocal laser scanning microscopy showed ChAT (choline acetyltransferase) activity in the EC of dermal blood vessels. Positive ChAT immunoreactivity was also demonstrated in monolayer cultures of human umbilical vein EC (HUVEC) and a human angiosarcoma EC line (HAEND). That the synthesizing enzyme is not only present in EC, but also active was shown by measuring ChAT a…

PharmacologyNervous systemEndotheliumChemistryCholine acetyltransferaseMolecular biologyUmbilical veinmedicine.anatomical_structureVesicular acetylcholine transportermedicineVesicular Acetylcholine Transport ProteinsReceptorAcetylcholinemedicine.drugJapanese Journal of Pharmacology
researchProduct

The action of iontophoretically applied acetylcholine and dopamine on single claustrum neurones in the cat.

1981

Abstract The effects of iontophoretically applied acetyl-choline (ACh) and dopamine (DA) on spontaneously active claustral neurones, in chloralose-anaesthetised cats, have been investigated. Acetylcholine had both facilitatory and inhibitory effects in almost the same proportions. The action of DA was prevalently inhibitory. Two types of inhibitory response to ACh and DA are described: short-lasting inhibition and long-lasting inhibition. The excitatory response always outlasted the period of drug application.

PharmacologyNeuronsCATSChemistryDopamineNeural InhibitionDrug applicationIontophoresisInhibitory postsynaptic potentialClaustrumAcetylcholineBasal GangliaCellular and Molecular NeuroscienceDopamineExcitatory postsynaptic potentialmedicineCatsAnimalsNeuroscienceAcetylcholinemedicine.drugNeuropharmacology
researchProduct

The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans.

1999

1. Acetylcholine (ACh) represents one of the most exemplary neurotransmitters. In addition to its presence in neuronal tissue, there is increasing experimental evidence that ACh is widely expressed in pro- and eukaryotic non-neuronal cells. Thus, ACh has been detected in bacteria, algae, protozoa, tubellariae and primitive plants, suggesting an extremely early appearance of ACh in the evolutionary process. 2. In humans, ACh and/or the synthesizing enzyme, choline acetyltransferase, has been demonstrated in epithelial cells (airways, alimentary tract, urogenital tract, epidermis), mesothelial (pleura, pericardium) and endothelial and muscle cells. In addition, immune cells express the non-ne…

PharmacologyNeuronsPhysiologyCellular differentiationBiologyCholine acetyltransferaseAcetylcholineCell biologyEvolution MolecularParacrine signallingNicotinic agonistBiochemistryPhysiology (medical)Muscarinic acetylcholine receptormedicineCholinergicAnimalsCholinesterasesHumansAcetylcholinemedicine.drugCalcium signalingClinical and experimental pharmacologyphysiology
researchProduct

Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans

2008

Animal life is controlled by neurons and in this setting cholinergic neurons play an important role. Cholinergic neurons release ACh, which via nicotinic and muscarinic receptors (n- and mAChRs) mediate chemical neurotransmission, a highly integrative process. Thus, the organism responds to external and internal stimuli to maintain and optimize survival and mood. Blockade of cholinergic neurotransmission is followed by immediate death. However, cholinergic communication has been established from the beginning of life in primitive organisms such as bacteria, algae, protozoa, sponge and primitive plants and fungi, irrespective of neurons. Tubocurarine- and atropine-sensitive effects are obser…

PharmacologyNicotinic agonistMuscarinic acetylcholine receptormedicineCholinergicBiologySignal transductionCholinergic neuronReceptorNeuroscienceAcetylcholineAcetylcholine receptormedicine.drugBritish Journal of Pharmacology
researchProduct

Influence of Drugs on Mild Cognitive Impairment in Parkinson’s Disease: Evidence from the PACOS Study

2022

Background: Polytherapy and the anticholinergic activity of several drugs negatively influence cognition in the elderly. However, little is known on the effect on Mild Cognitive Impairment (MCI) in Parkinson’s Disease (PD). Methods: Patients with PD belonging to the baseline PACOS cohort with full pharmacological data, have been included in this study. MCI diagnosis was made according to the MDS level II criteria. Polytherapy was defined as patients assuming ≥6 drugs. Anticholinergic burden has been calculated using the Anticholinergic Drug Scale (ADS). Molecules have been classified according to the ATC classification. Association with MCI has been assessed with a multivariate logistic re…

PharmacologyParkinson DiseaseGeneral MedicineMiddle AgedNeuropsychological TestspolytherapydrugsCholinergic Antagonistsanticholinergic burdenPsychiatry and Mental healthmild cognitive impairmentNeurologyParkinson’s diseaseHumansSettore MED/26 - NeurologiaCognitive DysfunctionPharmacology (medical)Neurology (clinical)polypharmacyAgedCurrent Neuropharmacology
researchProduct